UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 554

Sortiert nach

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2012-01, Vol.7 (1), p.196-202

2012

Link zum Volltext

Verfügbarkeit prüfen

Carpal Tunnel Syndrome Associated with the Use of Aromatase Inhibitors in Breast Cancer

Clinical breast cancer, 2008-08, Vol.8 (4), p.362-365

2008

Link zum Volltext

Verfügbarkeit prüfen

Hypnosis in the Management of Sleep Disorders

1, 2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)

Gynecologic oncology, 2001-08, Vol.82 (2), p.317-322

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer

Cancer research (Chicago, Ill.), 1988-05, Vol.48 (9), p.2561-2567

1988

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Toremifene in Patients With Advanced Cancer

Journal of clinical oncology, 1992-04, Vol.10 (4), p.674-674

1992

Link zum Volltext

Verfügbarkeit prüfen

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity

JNCI : Journal of the National Cancer Institute, 1988-03, Vol.80 (1), p.60-63

1988

Link zum Volltext

Verfügbarkeit prüfen

In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease

Cancer research (Chicago, Ill.), 1986-10, Vol.46 (10), p.5413-5418

1986

Link zum Volltext

Verfügbarkeit prüfen

Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin

JNCI : Journal of the National Cancer Institute, 1988-11, Vol.80 (18), p.1451-1461

1988

Link zum Volltext

Verfügbarkeit prüfen

Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2

Cancer research (Chicago, Ill.), 1989-09, Vol.49 (17), p.4941-4944

1989

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of toremifene in patients with advanced cancer

Journal of clinical oncology, 1991-11, Vol.9 (11), p.2036-2041

1991

Link zum Volltext

Verfügbarkeit prüfen

Guillain-Barré syndrome following Campylobacter jejuni enteritis

Archives of neurology (Chicago), 1987-12, Vol.44 (12), p.1219

1987

Link zum Volltext

Verfügbarkeit prüfen

Intermittent Cushing's syndrome with an empty sella turcica

Archives of internal medicine (1960), 1982-11, Vol.142 (12), p.2185

1982

Link zum Volltext

Verfügbarkeit prüfen

the influence of autologous lymphokine‐activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin‐2

Cancer, 1990-12, Vol.66 (12), p.2457-2464

1990

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer

Breast cancer research and treatment, 1990-08, Vol.16 (S1), p.S-S

1990

Link zum Volltext

Verfügbarkeit prüfen

Clinical Science Review: Ectopic Hormone Syndromes

Cancer investigation, 1986, Vol.4 (6), p.543-554

1986

Link zum Volltext

Verfügbarkeit prüfen

“Eight‐drugs‐in‐one‐day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas

Cancer, 1989-06, Vol.63 (12), p.2475-2481

1989

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous Infusion

Cancer investigation, 1989, Vol.7 (3), p.213-223

1989

Link zum Volltext

Verfügbarkeit prüfen

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Critical reviews in oncology/hematology, 1989, Vol.9 (2), p.125-147

1989

Link zum Volltext

Verfügbarkeit prüfen

Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial

Cancer, 1985-02, Vol.55 (3), p.552-560

1985

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Infiltrating Lymphocytes and Interleukin-2 in Melanomas

The New England journal of medicine, 1989-05, Vol.320 (21), p.1418-1419

1989

Link zum Volltext

Verfügbarkeit prüfen

Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions

Cancer Immunology, Immunotherapy, 1988-02, Vol.26 (1), p.74-82

1988

Link zum Volltext

Verfügbarkeit prüfen

Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom

Cancer investigation, 1991, Vol.9 (1), p.35-48

1991

Link zum Volltext

Verfügbarkeit prüfen

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2

Cancer research (Chicago, Ill.), 1988-04, Vol.48 (7), p.1965-1971

1988

Link zum Volltext

Verfügbarkeit prüfen

Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity1

JNCI : Journal of the National Cancer Institute, 1988-03, Vol.80 (1), p.60-63

1988

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 554

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(471)
Mit Volltextzugriff
(492)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(377)
Life Sciences & Biomedicine
(314)
Humans
(246)
Female
(144)
Male
(142)
Biological And Medical Sciences
(100)
Adult
(90)
Middle Aged
(84)
Medical Sciences
(75)
Aged
(64)
Animals
(60)
Physical Sciences
(48)
Technology
(35)
Environmental Sciences & Ecology
(33)
Oncology
(33)
Environmental Sciences
(32)
Fundamental And Applied Biological Sciences. Psychology
(32)
Mice
(32)
Surgery
(32)
Neurosciences & Neurology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

Carpal Tunnel Syndrome Associated with the Use of Aromatase Inhibitors in Breast Cancer

Hypnosis in the Management of Sleep Disorders

Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer

Phase I Study of Toremifene in Patients With Advanced Cancer

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity

In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease

Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin

Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2

Phase I study of toremifene in patients with advanced cancer

Guillain-Barré syndrome following Campylobacter jejuni enteritis

Intermittent Cushing's syndrome with an empty sella turcica

the influence of autologous lymphokine‐activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin‐2

Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer

Clinical Science Review: Ectopic Hormone Syndromes

“Eight‐drugs‐in‐one‐day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas

Phase 1 Clinical Trial of Recombinant Interleukin-2: A Comparison of Bolus and Continuous Intravenous Infusion

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2

Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial

Tumor-Infiltrating Lymphocytes and Interleukin-2 in Melanomas

Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions

Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom

In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2

Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity1

Suchergebnisse filtern